Dr. Harold Varmus, director of the National Cancer Institute at the National Institutes of Health, is internationally recognized for his research on retroviruses and the genetic basis of cancer.
Cornell researchers have developed a new technique to understand the actions of key proteins required for cancer cells to proliferate. This could help guide the development of drugs currently in clinical trials.
Dr. Silvia C. Formenti, an international expert in the use of radiation therapy for the treatment of cancer, has been appointed chair of the newly established Department of Radiation Oncology at Weill Cornell Medical College.
A Cornell-led study of the genome and RNA of hookworm reveals for the first time which genes are activated and deactivated during key phases of infection. The findings could lead to more effective treatments.
Rats in New York City were found to carry a flea species capable of transmitting plague pathogens, according to a new study from a team of researchers from Cornell and Columbia.
A team of researchers at Weill Cornell has improved a nonsurgical procedure that safely and effectively corrects newborn ear deformities in just two weeks.
With a new NIH grant, investigators in the Tuberculosis Research Unit hope to catalyze research findings made in the lab and at Weill Cornell's GHESKIO clinic in Haiti into new, effective agents to replace current TB therapies.
How much money would be saved if one high-risk person was prevented from contracting HIV in the United States? A new Weill Cornell study provides the answer.
Three Cornell assistant professors have received fellowships from the Alfred P. Sloan Foundation, whose goal is to support "the next generation of scientific leaders."
